期刊文献+

卫生技术评估及其在医用耗材管理中的应用 被引量:18

HTA and its application in medical consumables management
在线阅读 下载PDF
导出
摘要 卫生技术评估(HTA)是对卫生技术特性、作用及影响的系统评估,主要目的是为医疗领域中与技术有关的决策提供信息,促进具有成本效益的新技术的应用,并避免不能保障安全性和效益的技术应用于临床。综述国内外HTA研究进展及其在医用耗材管理中的应用及作用,为进一步推动HTA在我国医用耗材领域的规范化发展提供借鉴。 Health technology assessment(HTA) refers to the systematic assessment of the characteristics, effects and impacts of health technologies. Its main purpose is to provide information on decision-making that relates with technique in the medical field, and promote the application of new technologies with cost-effectiveness, and avoid the application of technologies whose clinical safety and benefits are uncertain. This paper reviews the research progress of HTA at home and abroad and its application and effect in the management of medical consumables so as to provide a reference for further promoting the standardized development of HTA in the field of medical consumables in China.
作者 聂海鑫 NIE Hai-xin(Department of Medical Engineering,Beijing Obstetrics and Gynecology Hospital,Capital Medical University,Beijing 100026,China)
出处 《中国医学装备》 2020年第9期213-217,共5页 China Medical Equipment
关键词 卫生技术评估(HTA) 医用耗材 医疗器械 医疗新技术 Health technology assessment(HTA) Medical consumables Medical devices New medical technologies
作者简介 通信作者:聂海鑫,男,(1980-),硕士,高级工程师,研究方向:医疗设备、电子信息、医用耗材及体外诊断试剂,nhx80102@163.com。
  • 相关文献

参考文献9

二级参考文献89

  • 1李新.高值医用耗材管理流程初探[J].广西大学学报(哲学社会科学版),2009,31(S2):96-97. 被引量:10
  • 2杨海.通过加强医用耗材管理降低病人负担[J].现代医院管理,2007,5(3):21-23. 被引量:7
  • 3Bingefors K,Pashos CL,Smith MD,Berger ML.Health Care Cost,Quality,and Outcomes:ISPOR Book of Terms.Lawrenceville,NJ:International Society for Pharmacoeconomics & Outcomes Research.2003.
  • 4Institute of Medicine.Assessing Medical Technologies.Washington,DC:National Academy Press.1985.
  • 5National Coordinating Centre for HTA.Annual Report of the NHS Health Technology Assessment Programme 1998.London:Department of Health,1998.
  • 6Kunkle GC.New challenge or the past revisited:the office of technology assessment in historical context.Technol Soc,1995,17:175-196.
  • 7Kaiser Family Foundation.Health care costs:a primer[O/L].[2008-05-04].http://www.kff.org.
  • 8Neumann PJ,Divi N,Beinfeld MT,et al.Medicare's national coverage decisions,1999 2003:quality of evidence and review times.Health Aff,2005,24:243-254.
  • 9Neumann PJ,Rosen AB,Weinstein MC.Medicare and costeffectiveness analysis.New Eng1 J Med,2005,353:1516-1522.
  • 10Gibson M,Santa J.The drug effectiveness review project:an important step forward.Health Aff,2006,26:W272-275.

共引文献153

同被引文献235

引证文献18

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部